Roquefort Therapeutics (LSE:ROQ) Beginning Cash Position : £1.38 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Beginning Cash Position?

Roquefort Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2023 was £1.38 Mil.

Roquefort Therapeutics's quarterly Beginning Cash Position declined from Dec. 2022 (£3.23 Mil) to Jun. 2023 (£2.32 Mil) and declined from Jun. 2023 (£2.32 Mil) to Dec. 2023 (£1.38 Mil).

Roquefort Therapeutics's annual Beginning Cash Position increased from Dec. 2021 (£0.00 Mil) to Dec. 2022 (£0.90 Mil) and increased from Dec. 2022 (£0.90 Mil) to Dec. 2023 (£2.32 Mil).

Roquefort Therapeutics Beginning Cash Position Historical Data

The historical data trend for Roquefort Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Beginning Cash Position Chart

Roquefort Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Beginning Cash Position

0.90

2.32

Roquefort Therapeutics Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	0.12	0.90	3.23	2.32	1.38

Roquefort Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Roquefort Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Roquefort Therapeutics (LSE:ROQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ROQAF:USA

Address

85 Great Portland Street, First Floor, London, GBR, W1W 7LT

Website

https://www.roquefortplc.com

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.

Roquefort Therapeutics (LSE:ROQ) Headlines

No Headlines